Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach

Antipsychotic medication can be often associated with sexual dysfunction (SD). Given its intimate nature, treatment emergent sexual dysfunction (TESD) remains underestimated in clinical practice. However, psychotic patients consider sexual issues as important as first rank psychotic symptoms, and th...

Full description

Bibliographic Details
Main Authors: Angel L. Montejo, Rubén de Alarcón, Nieves Prieto, José Mª Acosta, Bárbara Buch, Laura Montejo
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/2/308
_version_ 1797411003200176128
author Angel L. Montejo
Rubén de Alarcón
Nieves Prieto
José Mª Acosta
Bárbara Buch
Laura Montejo
author_facet Angel L. Montejo
Rubén de Alarcón
Nieves Prieto
José Mª Acosta
Bárbara Buch
Laura Montejo
author_sort Angel L. Montejo
collection DOAJ
description Antipsychotic medication can be often associated with sexual dysfunction (SD). Given its intimate nature, treatment emergent sexual dysfunction (TESD) remains underestimated in clinical practice. However, psychotic patients consider sexual issues as important as first rank psychotic symptoms, and their disenchantment with TESD can lead to important patient distress and treatment drop-out. In this paper, we detail some management strategies for TESD from a clinical perspective, ranging from prevention (carefully choosing an antipsychotic with a low rate of TESD) to possible pharmacological interventions aimed at improving patients’ tolerability when TESD is present. The suggested recommendations include the following: prescribing either aripiprazole or another dopaminergic agonist as a first option antipsychotic or switching to it whenever possible. Whenever this is not possible, adjunctive treatment with aripiprazole seems to also be beneficial for reducing TESD. Some antipsychotics, like olanzapine, quetiapine, or ziprasidone, have less impact on sexual function than others, so they are an optimal second choice. Finally, a variety of useful strategies (such as the addition of sildenafil) are also described where the previous ones cannot be applied, although they may not yield as optimal results.
first_indexed 2024-03-09T04:38:42Z
format Article
id doaj.art-103687f1d49048bbb852d5f377180000
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T04:38:42Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-103687f1d49048bbb852d5f3771800002023-12-03T13:23:53ZengMDPI AGJournal of Clinical Medicine2077-03832021-01-0110230810.3390/jcm10020308Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical ApproachAngel L. Montejo0Rubén de Alarcón1Nieves Prieto2José Mª Acosta3Bárbara Buch4Laura Montejo5Psychiatry Service, Clinical Hospital of the University of Salamanca, 37007 Salamanca, SpainPsychiatry Service, Infanta Elena Hospital, Juan Ramon Jiménez Hospital, Ronda Exterior Norte S/N, 21080 Huelva, SpainPsychiatry Service, Clinical Hospital of the University of Salamanca, 37007 Salamanca, SpainInstitute of Biomedical Research of Salamanca (IBSAL), Paseo San Vicente SN, 37007 Salamanca, SpainInstitute of Biomedical Research of Salamanca (IBSAL), Paseo San Vicente SN, 37007 Salamanca, SpainBarcelona Bipolar and Depressive Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Hospital Clinic of Barcelona, 08401 Catalonia, SpainAntipsychotic medication can be often associated with sexual dysfunction (SD). Given its intimate nature, treatment emergent sexual dysfunction (TESD) remains underestimated in clinical practice. However, psychotic patients consider sexual issues as important as first rank psychotic symptoms, and their disenchantment with TESD can lead to important patient distress and treatment drop-out. In this paper, we detail some management strategies for TESD from a clinical perspective, ranging from prevention (carefully choosing an antipsychotic with a low rate of TESD) to possible pharmacological interventions aimed at improving patients’ tolerability when TESD is present. The suggested recommendations include the following: prescribing either aripiprazole or another dopaminergic agonist as a first option antipsychotic or switching to it whenever possible. Whenever this is not possible, adjunctive treatment with aripiprazole seems to also be beneficial for reducing TESD. Some antipsychotics, like olanzapine, quetiapine, or ziprasidone, have less impact on sexual function than others, so they are an optimal second choice. Finally, a variety of useful strategies (such as the addition of sildenafil) are also described where the previous ones cannot be applied, although they may not yield as optimal results.https://www.mdpi.com/2077-0383/10/2/308antipsychoticsexual dysfunctionerectile dysfunctionanorgasmiaorgasm retardationTESD
spellingShingle Angel L. Montejo
Rubén de Alarcón
Nieves Prieto
José Mª Acosta
Bárbara Buch
Laura Montejo
Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
Journal of Clinical Medicine
antipsychotic
sexual dysfunction
erectile dysfunction
anorgasmia
orgasm retardation
TESD
title Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
title_full Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
title_fullStr Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
title_full_unstemmed Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
title_short Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
title_sort management strategies for antipsychotic related sexual dysfunction a clinical approach
topic antipsychotic
sexual dysfunction
erectile dysfunction
anorgasmia
orgasm retardation
TESD
url https://www.mdpi.com/2077-0383/10/2/308
work_keys_str_mv AT angellmontejo managementstrategiesforantipsychoticrelatedsexualdysfunctionaclinicalapproach
AT rubendealarcon managementstrategiesforantipsychoticrelatedsexualdysfunctionaclinicalapproach
AT nievesprieto managementstrategiesforantipsychoticrelatedsexualdysfunctionaclinicalapproach
AT josemaacosta managementstrategiesforantipsychoticrelatedsexualdysfunctionaclinicalapproach
AT barbarabuch managementstrategiesforantipsychoticrelatedsexualdysfunctionaclinicalapproach
AT lauramontejo managementstrategiesforantipsychoticrelatedsexualdysfunctionaclinicalapproach